Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.33M Sell
116,663
-108,937
-48% -$7.59M 0.09% 240
2025
Q4
$15M Buy
225,600
+132,800
+143% +$8.59M 0.19% 162
2025
Q3
$6.24M Buy
92,800
+92,500
+30,833% +$7.32M 0.08% 254
2025
Q2
$26.2K Buy
+300
New +$23.5K ﹤0.01% 465
2024
Q4
Sell
-115,500
Closed -$7.74M 414
2024
Q3
$7.74M Buy
+115,500
New +$9.48M 0.11% 260
2023
Q3
Sell
-42,100
Closed -$5.41M 356
2023
Q2
$5.41M Buy
42,100
+6,300
+18% +$762K 0.14% 355
2023
Q1
$4.16M Sell
35,800
-3,400
-9% -$381K 0.11% 411
2022
Q4
$4.44M Sell
39,200
-1,600
-4% -$176K 0.13% 345
2022
Q3
$3.29M Sell
40,800
-4,900
-11% -$415K 0.11% 391
2022
Q2
$3.41M Buy
+45,700
New +$4.17M 0.1% 432
2021
Q4
$1.34M Buy
+10,000
New +$1.44M 0.03% 524
2021
Q1
Sell
-32,400
Closed -$3M 588
2020
Q4
$3M Sell
32,400
-23,200
-42% -$2.07M 0.07% 526
2020
Q3
$5.73M Sell
55,600
-25,600
-32% -$2.67M 0.16% 307
2020
Q2
$8.23M Sell
81,200
-13,200
-14% -$1.18M 0.24% 62
2020
Q1
$6.36M Buy
94,400
+38,800
+70% +$2.41M 0.23% 57
2019
Q4
$3.04M Buy
55,600
+5,600
+11% +$266K 0.09% 554
2019
Q3
$1.87M Sell
50,000
-22,000
-31% -$855K 0.06% 609
2019
Q2
$2.7M Sell
72,000
-12,400
-15% -$390K 0.08% 583
2019
Q1
$2.51M Buy
+84,400
New +$2.97M 0.07% 575

Other funds holding DXCM

Andra AP-fonden's DXCM Position: Q1 2026 in Review

Andra AP-fonden reduced its DexCom (DXCM) stake by 48% in Q1 2026, selling an estimated $7.59M and leaving 116,663 shares worth $7.33M. The position accounts for 0.09% of the portfolio, ranked #240.

Andra AP-fonden first reported a position in DXCM in Q1 2019 and has held it in 19 quarters since. The position peaked at $15M in Q4 2025. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Andra AP-fonden held 116,663 shares of DexCom worth $7.33M as of Q1 2026.
  • Andra AP-fonden sold 108,937 DexCom shares in Q1 2026, an estimated $7.59M.
  • DexCom made up 0.09% of Andra AP-fonden's portfolio in Q1 2026, its #240 holding.
  • Andra AP-fonden first reported a position in DexCom in Q1 2019 and has held it in 19 quarters since.
  • Andra AP-fonden's DexCom position peaked at $15M in Q4 2025.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.